Medina Manuel Hidalgo sold $143k of GH
director at Guardant Health, Inc.. 1,500 shares at an average of $95.19, traded Nov 7, 2025, filed Nov 10, 2025.
Score components
- +15RoleDirector
- +11Trade size$143k at market
- +20Share of holdings soldSold 65% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001865525-25-000011, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | MOption exercise Common Stock | +1,000 | $32.55 | $33k | 2,315 | Nov 10, 2025 |
| Nov 7, 2025 | SOpen-market sale Common Stock | -1,000 | $95.17 | $95k | 1,315 | Nov 10, 2025 |
| Nov 7, 2025 | SOpen-market sale Common Stock | -500 | $95.23 | $48k | 815 | Nov 10, 2025 |
| Nov 7, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -1,000 | $0.00 | $0 | 16,029 | Nov 10, 2025 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 20Weak | GHsell Guardant Health, Inc. | Michael Brian Bell Chief Financial Officer | $261k 3,000 shares | -6% | |
| 10Weak | Guardant Health, Inc. | Musa Tariq director | $12k 116 shares | -1% | |
| 59Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $567k 5,451 shares | -44% | |
| 65Notable | Guardant Health, Inc. | Helmy Eltoukhy Co-Chief Executive Officer | $9.4M 90,565 shares | -4% | |
| 75Notable | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $2.4M 22,935 shares | -106% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.